Roche Finance Ltd 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:52 pm Sale |
2022-12-31 | 13G | Eloxx Pharmaceuticals, Inc. ELOX |
Roche Finance Ltd | 1,893 0.100% |
-123,080 (-98.49%) |
Filing |
| 2022-02-14 06:18 am Purchase |
2021-12-31 | 13G | Eloxx Pharmaceuticals, Inc. ELOX |
Roche Finance Ltd | 124,973 5.800% |
61,667 (+97.41%) |
Filing |
| 2021-06-14 4:01 pm Purchase |
2021-04-01 | 13G | Eloxx Pharmaceuticals, Inc. ELOX |
Roche Finance Ltd | 63,307 5.300% |
63,307 (New Position) |
Filing |